TMBIM4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.475980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.885400E-01
Normal-vs-Stage2
6.875700E-03
Normal-vs-Stage3
5.965500E-02
Normal-vs-Stage4
7.227000E-01
Stage1-vs-Stage2
2.266800E-01
Stage1-vs-Stage3
5.156400E-02
Stage1-vs-Stage4
4.605600E-01
Stage2-vs-Stage3
1.759800E-01
Stage2-vs-Stage4
9.207000E-01
Stage3-vs-Stage4
2.321600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.518400E-02
Normal-vs-AfricanAmerican
7.467600E-01
Normal-vs-Asian
2.108800E-01
Caucasian-vs-AfricanAmerican
8.636400E-01
Caucasian-vs-Asian
3.846800E-01
AfricanAmerican-vs-Asian
5.208400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.623980E-01
Normal-vs-Female
4.010000E-02
Male-vs-Female
6.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.483600E-01
Normal-vs-Age(41-60Yrs)
6.457600E-01
Normal-vs-Age(61-80Yrs)
2.081300E-03
Normal-vs-Age(81-100Yrs)
6.152400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.451000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.609200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.698600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.480500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.717400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.715200E-03
Normal-vs-Daily Drinker
2.532000E-02
Normal-vs-Weekly Drinker
3.883200E-01
Normal-vs-Occasional Drinker
2.974000E-01
Normal-vs-Social Drinker
5.705000E-01
Non Drinker-vs-Daily Drinker
8.316800E-01
Non Drinker-vs-Weekly Drinker
8.366000E-01
Non Drinker-vs-Occasional Drinker
1.180120E-02
Non Drinker-vs-Social Drinker
3.404400E-01
Daily Drinker-vs-Weekly Drinker
9.235400E-01
Daily Drinker-vs-Occasional Drinker
2.952000E-02
Daily Drinker-vs-Social Drinker
4.620400E-01
Weekly Drinker-vs-Occasional Drinker
1.752580E-01
Weekly Drinker-vs-Social Drinker
7.017600E-01
Occasional Drinker-vs-Social Drinker
2.560000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.862400E-02
Normal-vs-Grade 2
1.049680E-02
Normal-vs-Grade 3
7.411900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.466800E-01
Grade 1-vs-Grade 3
3.667600E-01
Grade 1-vs-Grade 4
3.862400E-02
Grade 2-vs-Grade 3
5.254600E-01
Grade 2-vs-Grade 4
1.049680E-02
Grade 3-vs-Grade 4
7.411900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.534000E-01
Normal-vs-NonDiabetic
4.441100E-03
Diabetic-vs-NonDiabetic
7.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.336600E-03
Normal-vs-NoPancreatitis
3.590000E-02
Pancreatitis-vs-NoPancreatitis
4.088400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.307600E-01
Normal-vs-N1
1.554210E-02
N0-vs-N1
5.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.797400E-01
Normal-vs-TP53-NonMutant
9.257200E-01
TP53-Mutant-vs-TP53-NonMutant
7.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
